[THE INVESTOR] Kolmar Korea will grow significantly next year, said SK Securities on Oct. 15, initiating coverage with a “buy” recommendation and 94,000 won (US$82.95) target price.
Its estimated earnings per share growth rate next year is much higher than other Korean cosmetics manufacturers and competitiveness of its pharmaceutical ODM sector is noticeable. Its cosmetics unit will gain systematically compared to other global cosmetics manufacturers, as it has relatively less exposure to risks from China, said analyst Cheon Yeong-hyeon.
The company’s profits will grow in earnest from next year and revenue in 2019 will hike 26.2 percent from this year to 1.67 trillion won and operating profit by 89.1 percent to 171.0 billion won, the analyst forecast.
By Hwang You-mee (firstname.lastname@example.org)